.jpg "Steven J. Chmura, MD, PhD photo")
Professor of Radiation and Cellular Oncology and Medical Oncology
University of Chicago Medicine
Chicago, IL, United States
Dr. Steven J. Chmura is a Professor in the Department of Radiation and Cellular Oncology and Hematology Oncology, and the Scientific Director of the Cancer Clinical Trials Office
Steven J. Chmura MD, PhD is the director of Clinical and Translational Research for Radiation Oncology at the University of Chicago for over a decade and now is the Scientific Director of the Cancer Clinical Trials at the University of Chicago Comprehensive Cancer Center. He has been actively involved in both the clinical implementation of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). His main interests and research focus on translational and clinical trial development in the developmental therapeutics space. Dr. Chmura is a leader in the NCI cooperative groups and has led to the first international oligometastatic trials through NRG Oncology examining the safety of treating oligometastatic patients (NRG BR001) as well as the ongoing Phase II/III trial examining potential improvements to progression-free survival and overall survival of SBRT in patients with oligometastatic breast cancer (NRG BR002). Dr. Chmura's work in radio-immunology has also translated into multiple investigator-sponsored and NCI trials examining the role of SBRT combined with immunotherapy agents; such integration of ablative radiotherapy and immunotherapy along with advancing the search for biomarkers is currently Dr. Chmura's focus.
Astellas Pharm (Individual(s) Involved: Spouse/Partner): Employment (full or part time); AstraZeneca (Individual(s) Involved: Self): Consultant/Advisory Board, Research Grant; Bristol-Myers Squibb (Individual(s) Involved: Self): Research Grant; genentec (Individual(s) Involved: Self): Consultant/Advisory Board; Takeda Pharma (Individual(s) Involved: Self): Grant/Research Support
Saturday, March 12, 2022
10:10 AM – 11:10 AM US EST